Combined modality therapy of esophageal cancer

Rosalyn A. Juergens, Arlene Forastiere

Research output: Contribution to journalReview articlepeer-review

14 Scopus citations


Esophageal cancer is a deadly disease. Only one third of patients with localized disease experience long-term survival. Over the past 20 years, investigators have evaluated neoadjuvant strategies to improve the outcomes of surgical management. Chemotherapy and radiation have been evaluated individually and in combination for preoperative management of patients with localized esophageal cancer. This article provides a critical review of the data on multi-modality approaches to the management of esophageal cancer.

Original languageEnglish (US)
Pages (from-to)851-860
Number of pages10
JournalJNCCN Journal of the National Comprehensive Cancer Network
Issue number9
StatePublished - Oct 2008


  • Chemoradiotherapy
  • Chemotherapy
  • Esophageal cancer
  • Neoadjuvant

ASJC Scopus subject areas

  • Oncology


Dive into the research topics of 'Combined modality therapy of esophageal cancer'. Together they form a unique fingerprint.

Cite this